MAP2K2
MAP2K2 mitogen-activated protein kinase kinase 2
MAP2K2; mitogen-activated protein kinase kinase 2; PRKMK2; dual specificity mitogen-activated protein kinase kinase 2; MEK2; MAPK/ERK kinase 2; MAP kinase kinase 2; ERK activator kinase 2; mitogen-activated protein kinase kinase 2, p45; MKK2; MAPKK2; FLJ26075;
MAPK3
MAPK3 mitogen-activated protein kinase 3
MAPK3; mitogen-activated protein kinase 3; PRKM3; ERK1; p44erk1; p44mapk; MAPK 1; MAP kinase 1; MAP kinase 3; MAP kinase isoform p44; insulin-stimulated MAP2 kinase; mitogen-activated protein kinase 1; extracellular signal-related kinase 1; extracellular signal-regulated kinase 1; microtubule-associated protein 2 kinase; ERT2; ERK-1; P44ERK1; P44MAPK; HS44KDAP; HUMKER1A; p44-ERK1; p44-MAPK; MGC20180;
MAPK9
MAPK9 mitogen-activated protein kinase 9
MAPK9; mitogen-activated protein kinase 9; PRKM9; JNK2; Jun kinase; p54a; SAPK; MAPK 9; MAP kinase 9; c-Jun kinase 2; c-Jun N-terminal kinase 2; stress-activated protein kinase 1a; stress-activated protein kinase JNK2; JNK2A; JNK2B; JNK-55; SAPK1a; JNK2BETA; p54aSAPK; JNK2ALPHA;
MAPKSP1
LAMTOR3 late endosomal/lysosomal adaptor, MAPK and MTOR activator 3
MP1; MAPBP; MAPKSP1; MAP2K1IP1; Ragulator3; ragulator complex protein LAMTOR3; PRO0633; MEK partner 1; OTTHUMP00000161681; OTTHUMP00000219461; MEK binding partner 1; MEK-binding partner 1; MAPK scaffold protein 1; mitogen-activated protein kinase scaffold protein 1; late endosomal/lysosomal adaptor and MAPK and MTOR activator 3; mitogen-activated protein kinase kinase 1 interacting protein 1; mitogen-activated protein kinase kinase 1-interacting protein 1;
MARK1
MAP/microtubule affinity-regulating kinase 1
MARK1; MAP/microtubule affinity-regulating kinase 1; serine/threonine-protein kinase MARK1; MARK; PAR1 homolog c; Par1c; Par-1c; KIAA1477; MGC126512; MGC126513;
MARK3
MAP/microtubule affinity-regulating kinase 3
MARK3; MAP/microtubule affinity-regulating kinase 3; CTAK1; KP78; EMK-2; C-TAK1; ELKL motif kinase 2; protein kinase STK10; ser/Thr protein kinase PAR-1; cdc25C-associated protein kinase 1; serine/threonine-protein kinase p78; PAR1A; Par-1a;
MBIP
MAP3K12 binding inhibitory protein 1
MBIP; MAP3K12 binding inhibitory protein 1; MAP3K12-binding inhibitory protein 1; MAPK upstream kinase binding inhibitory protein; MUK binding inhibitory protein; OTTHUMP00000178844; OTTHUMP00000244269; OTTHUMP00000244270; OTTHUMP00000244271; OTTHUMP00000244272; MUK-binding inhibitory protein; MAPK upstream kinase-binding inhibitory protein;
MKNK1
MAP kinase interacting serine/threonine kinase 1
MKNK1; MAP kinase interacting serine/threonine kinase 1; MAP kinase-interacting serine/threonine-protein kinase 1; MNK1; MAPK signal-integrating kinase 1; MAP kinase signal-integrating kinase 1;
MKNK2
MAP kinase interacting serine/threonine kinase 2
MKNK2; MAP kinase interacting serine/threonine kinase 2; G protein coupled receptor kinase 7 , GPRK7; MAP kinase-interacting serine/threonine-protein kinase 2; MNK2; Putative map kinase interacting kinase; MAP kinase signal integrating kinase 2; G protein coupled receptor kinase 7; GPRK7; MAP kinase interacting serine threonine kinase 2; MAP kinase interacting serine threonine kinase; MAP kinase interacting serine threonine protein kinase 2; MAP kinase signal-integrating kinase 2; MAPK interacting kinase 2; Mitogen activated protein kinase interacting serine threonine kinase 2; MKNK2_HUMAN; G protein-coupled receptor kinase 7;
SEMA3A
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
SEMA3A; sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A; HH16; SemD; COLL1; SEMA1; SEMAD; SEMAL; coll-1; Hsema-I; SEMAIII; Hsema-III; semaphorin-3A; collapsin 1; semaphorin D; semaphorin L; semaphorin III;
SEMA5A
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A
SEMA5A; sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A; semF; SEMAF; semaphorin-5A; sema F; semaphorin F; semaphorin-F; semaphorin 5A;
SEMA6B
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6B
SEMA6B;sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6B;SEMAN;semaphorin-6B;SEM SEMA Y;Sema VIb;SEMA VIB;semaphorin VIB;semaphorin Z;semaZ;semaphorin-6Ba;SEMA-VIB;SEM-SEMA-Y;
MAP2K5
MAP2K5 mitogen-activated protein kinase kinase 5
MAP2K5; mitogen-activated protein kinase kinase 5; PRKMK5; dual specificity mitogen-activated protein kinase kinase 5; HsT17454; MAPKK5; MEK5; MEK 5; MAPKK 5; MAPK/ERK kinase 5; MAP kinase kinase 5; MAP kinase kinase MEK5b;
MAP2K7
MAP2K7 mitogen-activated protein kinase kinase 7
MAP2K7; mitogen-activated protein kinase kinase 7; PRKMK7; dual specificity mitogen-activated protein kinase kinase 7; Jnkk2; MKK7; MEK 7; JNKK 2; MAPKK 7; SAPK kinase 4; MAPK/ERK kinase 7; MAP kinase kinase 7; JNK-activating kinase 2; c-Jun N-terminal kinase kinase 2; stress-activated protein kinase kinase 4; MAPKK7; SAPKK4; SAPKK-4;
MARK2
MAP/microtubule affinity-regulating kinase 2
MARK2; MAP/microtubule affinity-regulating kinase 2; ELKL motif kinase , EMK1; serine/threonine-protein kinase MARK2; ELKL motif kinase 1; PAR 1; Par1b; protein serine/threonine kinase; Ser/Thr protein kinase PAR 1B; serine/threonine kinase; PAR1 homolog;
SEMA4B
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B
SEMA4B; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B; SEMAC; semaphorin-4B; KIAA1745; MGC131831; SemC; Sema domain immunoglobulin domain (Ig) transmembrane domain (TM) and short cytoplasmic domain (semaphorin) 4B; Sema domain immunoglobulin domain (Ig) transmembrane domain (TM) and short cytoplasmic domain 4B; Semaphorin 4B; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, 4B;
SEMA4D
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
SEMA4D; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D; CD100; SEMAJ; coll-4; C9orf164; M-sema-G; semaphorin-4D; A8; GR3; BB18; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, 4D;
SEMA7A
sema domain, immunoglobulin domain (Ig), and GPI membrane anchor, (semaphorin) 7A
SEMA7A; sema domain, immunoglobulin domain (Ig), and GPI membrane anchor, (semaphorin) 7A; Semal; CDw108; H-Sema-L; M-Sema-L; 2900057C09Rik; semaphorin-7A; sema L; sema K1; H-Sema K1; semaphorin-L; Semaphorin K1; semaphorin-K1;
LAMTOR3
late endosomal/lysosomal adaptor, MAPK and MTOR activator 3
MP1; MAPBP; MAPKSP1; MAP2K1IP1; Ragulator3; ragulator complex protein LAMTOR3; PRO0633; MEK partner 1; OTTHUMP00000161681; OTTHUMP00000219461; MEK binding partner 1; MEK-binding partner 1; MAPK scaffold protein 1; mitogen-activated protein kinase scaffold protein 1; late endosomal/lysosomal adaptor and MAPK and MTOR activator 3; mitogen-activated protein kinase kinase 1 interacting protein 1; mitogen-activated protein kinase kinase 1-interacting protein 1; LAMTOR3;
TAB1
TGF-beta activated kinase 1/MAP3K7 binding protein 1
3"-Tab1; MGC57664; MAP3K7IP1; TGF-beta-activated kinase 1 and MAP3K7-binding protein 1; OTTHUMP00000199134; OTTHUMP00000199135; TAK1-binding protein 1; transforming growth factor beta-activated kinase-binding protein 1; mitogen-activated protein kinase kinase kinase 7-interacting protein 1; TAB1; TGF-beta activated kinase 1/MAP3K7 binding protein 1;
SEMA4A
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A
SEMA4A; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A; semaphorin-4A; sema B; semaphorin-B; semaphorin 4A; SemB; Semab; AI132332;
SEMA6A
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A
SEMA6A; sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A; VIA; SEMA; HT018; SEMAQ; SEMA6A1; semaphorin-6A; SEMA6A-1; sema VIa; semaphorin VIA; semaphorin 6A-1; semaphorin-6A-1;
GIMAP2
GTPase, IMAP family member 2
GIMAP2; GTPase, IMAP family member 2; GTPase IMAP family member 2; DKFZp586D0824; HIMAP2; IMAP2; Immunity associated protein 2; immunity-associated protein 2;
GIMAP4
GTPase, IMAP family member 4
GIMAP4; GTPase, IMAP family member 4; GTPase IMAP family member 4; FLJ11110; HIMAP4; IMAP4; hIAN1; IAN1; Immunity associated nucleotide 1 protein; Immunity associated protein 4; MSTP062; IAN-1; immunity-associated protein 4; human immune associated nucleotide 1; immunity-associated nucleotide 1 protein;
GIMAP5
GTPase, IMAP family member 5
GIMAP5; GTPase, IMAP family member 5; IAN4L1, immune associated nucleotide 4 like 1 (mouse); GTPase IMAP family member 5; HIMAP3; IAN4; IAN4L1; IAN5; IMAP3; FLJ11296; GIMAP 5; hIAN5; IAN 5; Immune associated nucleotide 4 like 1; Immunity associated nucleotide 4 like 1 protein; Immunity associated protein 3; immunity-associated nucleotide 5 protein; inhibitor of radiation- and OA-induced apoptosis, Irod/Ian5; IROD; IAN-5;
MAP3K7
mitogen-activated protein kinase kinase kinase 7
MAP3K7; mitogen-activated protein kinase kinase kinase 7; TAK1; MEKK7; TGF-beta activated kinase 1; TGF-beta-activated kinase 1; transforming growth factor-beta-activated kinase 1; TGF1a; MAP; MAP3K; mitogen-activated protein kinase 7;
MAP3K7IP1
TAB1 TGF-beta activated kinase 1/MAP3K7 binding protein 1
3'-Tab1; MGC57664; MAP3K7IP1; TGF-beta-activated kinase 1 and MAP3K7-binding protein 1; OTTHUMP00000199134; OTTHUMP00000199135; TAK1-binding protein 1; transforming growth factor beta-activated kinase-binding protein 1; mitogen-activated protein kinase kinase kinase 7-interacting protein 1;
SEMA4G
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G
SEMA4G; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G; semaphorin-4G; FLJ20590; KIAA1619; sema domain immunoglobulin domain (Ig) transmembrane domain (TM) and short cytoplasmic domain (semaphorin) 4G; semaphorin 4G; Semaphorin 4G precursor;
MARK4
MAP/microtubule affinity-regulating kinase 4
MARK4; MAP/microtubule affinity-regulating kinase 4; MAP/microtubule affinity regulating kinase like 1 , MARKL1; FLJ90097; KIAA1860; Nbla00650; MARK4 serine/threonine protein kinase; MAP/microtubule affinity-regulating kinase like 1; MARK4L; MARK4S; MARKL;
SEMA6C
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6C
SEMA6C; sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6C; semaphorin-6C; KIAA1869; m Sema Y2; m Sema Y; Sema Y; Semaphorin 6C [Precursor]; Semaphorin Y; SEMAY; semaphorin-Y; OTTHUMP00000014154; OTTHUMP00000014155; OTTHUMP00000014156; OTTHUMP00000014157; m-SemaY; m-SemaY2;
LAMTOR2
late endosomal/lysosomal adaptor, MAPK and MTOR activator 2
LAMTOR2; late endosomal/lysosomal adaptor, MAPK and MTOR activator 2; roadblock domain containing 3 , ROBLD3; ragulator complex protein LAMTOR2; ENDAP; endosomal adaptor protein; MAPBPIP; MAPKSP1 adaptor protein; MAPKSP1AP; mitogen activated protein bindi;
MADD
MAP-kinase activating death domain
MADD; MAP-kinase activating death domain; MAP kinase-activating death domain protein; DENN; KIAA0358; RAB3GEP; Rab3 GDP/GTP exchange factor; insulinoma glucagonoma clone 20; differentially expressed in normal and neoplastic cells; IG20; FLJ35600; FLJ36300;
GIMAP1
GTPase, IMAP family member 1
GIMAP1; GTPase, IMAP family member 1; GTPase IMAP family member 1; HIMAP1; IMAP1; IMAP38; immunity associated protein 1;
GIMAP3
GTPase, IMAP family member 3
GIMAP3; GTPase, IMAP family member 3; GTPase IMAP family member 3; GTPase, IMAP family member 3 pseudogene; Ian4; Gimap5; 2010110D23Rik; GIMAP 3; GTPase of the immune associated protein 3; Immune associated nucleotide 4; Immunity associated nucleotide 4 protein; IAN-4; immunity-associated nucleotide 4 protein;
GIMAP6
GTPase, IMAP family member 6
GIMAP6; GTPase, IMAP family member 6; GTPase IMAP family member 6; FLJ22690; GIMA6_HUMAN; hIAN2; hIAN6; Human immune associated nucleotide 2; IAN-2; IAN-6; IAN6; Immune associated nucleotide 2; Immune associated nucleotide 6; Immunity associated nucleotide 6 protein; Immunity-associated nucleotide 2 protein; Immunity-associated nucleotide 6 protein; IAN2;
GIMAP7
GTPase, IMAP family member 7
GIMAP7; GTPase, IMAP family member 7; GTPase IMAP family member 7; IAN7; MGC27027; hIAN7; IAN 7; Immune associated nucleotide; immunity associated nucleotide 7 protein; IAN-7; immunity-associated nucleotide 7 protein;
GIMAP8
GTPase, IMAP family member 8
GIMAP8; GTPase, IMAP family member 8; GTPase IMAP family member 8; DKFZp667I133; hIAN6; Human immune associated nucleotide 6; IAN9; IANT; Immune associated nucleotide; Immune-associated nucleotide-binding protein 9; Protein IanT; IAN6; IAN-9;
MAP6D1
MAP6 domain containing 1
MAP6D1; MAP6 domain containing 1; MAP6 domain-containing protein 1; FLJ12748; STOP-like protein 21; 21 kDa STOP-like protein; SL21; MAPO6D1;
MAP7D1
MAP7 domain containing 1
MAP7D1; MAP7 domain containing 1; arginine/proline rich coiled coil 1 , PARCC1, proline arginine rich coiled coil 1 , RPRC1; MAP7 domain-containing protein 1; FLJ10350; FLJ39022; arginine/proline rich coiled-coil 1; proline arginine rich coiled coil 1; a;
TAB3
TGF-beta activated kinase 1/MAP3K7 binding protein 3
TAB3; TGF-beta activated kinase 1/MAP3K7 binding protein 3; MAP3K7IP3, mitogen activated protein kinase kinase kinase 7 interacting protein 3; TGF-beta-activated kinase 1 and MAP3K7-binding protein 3; TAK1 binding protein 3; TAB-3; TAK1-binding protein 3;
SEMA6D
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D
SEMA6D; sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D; semaphorin-6D; FLJ11598; KIAA1479; Q8NFY4; Semaphorin 6D;
SEMA3E
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E
SEMA3E; sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E; SEMAH; semaphorin-3E; coll 5; KIAA0331; M sema H; M SemaK; coll-5; M-SEMAH; M-SemaK;
SEMA3F
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F
SEMA3F; sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F; SEMA4; SEMAK; SEMA-IV; semaphorin-3F; sema IV; sema III/F; semaphorin IV; semaphorin III/F; sema domain, immunoglobulin domain (Ig), short basic domain, secreted, 3F;
SEMA3G
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G
SEMA3G; sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G; semaphorin-3G; FLJ00014; sem2; MGC119473; Sema domain immunoglobulin domain (Ig) short basic domain secreted (semaphorin) 3G; Semaphorin 3G; Semaphorin sem2;
SEMA3B
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B
SEMA3B; sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B; SemA; SEMA5; SEMAA; semaV; LUCA-1; semaphorin-3B; sema A(V); semaphorin A; semaphorin-V;
SEMA3D
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D
SEMA3D; sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D; coll-2; Sema-Z2; semaphorin-3D; collapsin 2;
SGSM3
small G protein signaling modulator 3
SGSM3; small G protein signaling modulator 3; RUN and TBC1 domain containing 3 , RUTBC3; DJ1042K10.2; RabGAP 5; RABGAP5; RUN and SH3 containing 3; RUSC3; Cip85; R75178; rabGAPLP; RUN and TBC1 domain containing 3; RUTBC3; Bdif 1; Cx43 interacting protein of 85 kDa; MAP; Merlin associated protein; Merlin-associated protein; rab GTPase activating protein like protein; Rab-GTPase-activating protein-like protein; RUN and TBC1 domain containing protein 3; RUN and TBC1 domain-containing protein 3; SGSM3_HUMAN; Small G protein signaling modulator 3 protein; merlin binding protein; RabGAP-5;
SEMA4F
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4F
SEMA4F; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4F; SEMAM; semaphorin-4F; m Sema M; SEMAW; M SEMA; PRO2353; Sema domain immunoglobulin domain (Ig) transmembrane; Sema M; Sema W; Semaphorin M; Semaphorin W; semaphorin-M; semaphorin-W; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, 4F; M-SEMA; m-Sema-M;
TAB2
TGF-beta activated kinase 1/MAP3K7 binding protein 2
TAB2; TGF-beta activated kinase 1/MAP3K7 binding protein 2; MAP3K7IP2, mitogen activated protein kinase kinase kinase 7 interacting protein 2; TGF-beta-activated kinase 1 and MAP3K7-binding protein 2; KIAA0733; TAB-2; TAK1-binding protein 2; TGF-beta-act;
LAMTOR1
late endosomal/lysosomal adaptor, MAPK and MTOR activator 1
LAMTOR1;late endosomal/lysosomal adaptor, MAPK and MTOR activator 1;26068;ENSG00000149357;p18;PDRO;C11orf59;p27RF-Rho;Ragulator1;11q13.4;FLJ20625;ragulator complex protein LAMTOR1;ragulator complex protein LAMTOR1;RhoA activator C11orf59;lipid raft adaptor protein p18;ragulator complex protein PDRO;p27Kip1-releasing factor from RhoA;p27kip1 releasing factor from RhoA;protein associated with DRMs and endosomes;late endosomal/lysosomal adaptor and MAPK and MTOR activator 1;
SEMA3C
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C [ Homo sapie
SEMA3C;sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C;10725;ENSG00000075223;SemE;SEMAE;7q21-q31;semaphorin-3C;semaphorin-3C;sema E;semaphorin E;semaphorin-E;
MAP7D2
MAP7 domain containing 2
Map7d2; RP23-39I7.2; 1600028E09Rik; 2900002G04Rik; 5330432J06Rik; C030036K04Rik;
Protein Phosphorylation Site Identification and Mapping Service
Creative BioMart provides for the detection of phosphosites located in a target protein that has been phosphorylated in vivo and purified by immuno-precipitation or a recombinant protein that has been phosphorylated in vitro with a purified protein kinase. Our speciality is the identification of pr...
Epitope Mapping
Epitope mapping has become more and more vital in both vaccine and antibody drug development. Knowledge on epitope of an antibody will largely facilitate your drug design and patent application. Based on our advanced peptide library platform, Creative BioMart provides a comprehensive series of Epito...
Protein Binding Site Mapping
Understanding how proteins interact on a residue level is essential during the early stages of drug design and the later stages of lead optimization. It is equally important to identify the locations of any potential allosteric binding sites. This requires researchers to discover the location of pro...
Nature Genetics: the Mapping of Telomerase was Disclosed for the First Time
Telomerase is an important enzyme that adds DNA sequence repeats to the 3 end of DNA strands in the telomere region. It is one of the fundamental enzymes in cell biology. It is a reverse transcriptase and shortened after every replication cycle. In 1970s, scientists have assumed that it was ...
Learn More about Epitope Mapping
Epitope mapping, a process of identifying the binding sites of antibodies on their target antigens, is more and more vital for the discovery and development of new therapeutics, vaccines and antibody drug development. Epitope can be divided into two categories that are linear and conformationa...
What is MAPT Protein
See All MAPT Protein Products Microtubule-associated protein tau (MAPT) stands as a linchpin in cellular biology, orchestrating a symphony of functions within the neurons of the central nervous system. What is MAPT Protein? MAPT, encoded by the MAPT gene on chromosome 17, exhibits a sophisticated ...
What is MAP2K3 Protein?
See All MAP2K3 Products The MAP2K3 (Mitogen-Activated Protein Kinase Kinase 3) protein is a highly critical component of mammalian cells because of its key roles in signaling pathways, cellular development, differentiation, and response to extracellular stimuli. A deeper understanding of this protei...
